Evaluate Ltd. Appoints Deborah Kobewka as Chief Executive Officer
Evaluate Ltd., the leading provider of commercial data to the life sciences industry, is pleased to announce the appointment of Deborah Kobewka as Chief Executive Officer, effective immediately. Deborah succeeds Alex Karle, who joined Evaluate in 2012 as Chief Operating Officer before assuming the role of CEO in 2014.
Deborah brings to Evaluate over 30 years of expertise in the global pharmaceutical, healthcare and information sectors. With her successful track record of driving commercial expansion, she is well positioned to accelerate the company’s current growth trajectory.
Deborah joins Evaluate from the Department for International Trade in the UK government where she served as Managing Director of Healthcare UK, Lifesciences and Bio-economy. Prior to that, she held senior corporate and operational roles at both private and government organisations in the UK, Europe and Asia, including 24 years at IMS Health (now IQVIA).
“Evaluate has an impressive history of pioneering solutions for life science decision makers,” said Deborah Kobewka. “I’m honoured to be leading the organisation as we embark on our next phase of innovation, and look forward to delivering new resources that improve results for both our clients and the wider industry.”
“We’re delighted to welcome Deborah to Evaluate,” said Jonathan de Pass, Chairman at Evaluate. “We’ve experienced impressive growth over the last several years and Deborah is the perfect leader to build on this success. Deborah’s deep knowledge of our sector and clients will be invaluable in driving our strategy as Evaluate continues to grow and evolve.”
Jonathan continued: “On behalf of Evaluate’s Board of Directors, I would also like to thank Alex Karle for his enormous contribution leading the company over the last six and a half years. Our business became immeasurably stronger throughout his tenure, and we wish him every success in the next phase of his career.”
About Evaluate Ltd.
Evaluate provides trusted commercial intelligence for the pharmaceutical and medical device industries. Our EvaluatePharma® online subscription services provide a seamless view of the past, present and future of the global pharmaceutical market in a single, standardised platform.
Vantage – our award-winning, independent editorial team – provides thought-provoking news and insights into the current and future developments in the industry.
Evaluate has been a partner to industry-leading organisations for over 20 years. For more information on how we give our clients the time and understanding to drive better decisions, visit www.evaluate.com.
Follow us on Twitter: @EvaluatePharma, @EvaluateMedtech, @Vantageanalysis
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190326005131/en/
Contact information
Evaluate Ltd.
Jennifer Dinkel
+1 617-936-7783
jennifer.dinkel@evaluate.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Delivers a Strong Start to the Year With Record Net Sales of Over 1 Billion USD for the First Quarter and 12.4% Year-on-Year Growth24.4.2024 08:00:00 EEST | Press release
Galderma Group AG (SWX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2024. Record net sales of 1.071 billion USD in the first quarter of 2024, surpassing for the first time the 1 billion USD mark for the first three months in a year Net sales growth for the first quarter of 2024 was 12.4% year-on-year on a constant currency basis1 , primarily driven by volume Broad-based growth across all product categories, with constant currency year-on-year growth of 19.3% for Injectable Aesthetics, 8.4% for Dermatological Skincare, and 4.1% for Therapeutic Dermatology Growth across geographies, especially in International markets while U.S. growth accelerated year-on-year 2024 full year guidance confirmed: 7-10% net sales year-on-year growth at constant currency and Core EBITDA margin in line with 2023 at constant currency Continued execution of Galderma’s integrated dermatology strategy, progressing on its innovation pipeline, comm
FPT Cooperates with USAID to Promote Clean Energy Deployment, Reduce Greenhouse Gas Emissions, and Accelerate Net Zero Transition24.4.2024 07:35:00 EEST | Press release
FPT Corporation signed Letter of Cooperation with the United States Agency for International Development’s (USAID) Vietnam Low Emission Energy Program II (V-LEEP II), with the goal of supporting the corporation in achieving the Net Zero target by 2040, a decade earlier than Vietnam's commitment. FPT is Vietnam’s first technology firm to collaborate with V-LEEP II. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240423349833/en/ The signing ceremony was attended by FPT Corporation Senior Executive Vice President Nguyen The Phuong, FPT Software Senior Executive Vice President Nguyen Khai Hoan, and USAID/Vietnam Deputy Mission Director Bradley Bessire (Photo: Business Wire) In accordance with the agreements, V-LEEP II will provide technical assistance to FPT from April 2024 to April 2025 as the corporation formulates a plan to execute its net-zero commitments. This entails providing a comprehensive understanding of Net Zero stra
Binarly Launches Next-Generation Transparency Platform to Elevate Software Supply Chain Security23.4.2024 19:00:00 EEST | Press release
Binarly, provider of an industry leading AI-powered firmware and software supply chain security platform, announces the release of the Binarly Transparency Platform v2.0 with features for continuous post-build compliance, visibility into the security posture of IoT and XIoT devices, and the ability to identify malicious behavior and hidden backdoors within binaries based on their behavior. Learn more here. Based on the company’s proprietary Binary Risk Intelligence technology, the new innovations underscore Binarly's commitment to pioneering solutions that enhance transparency and security across firmware and software ecosystems. Founded in 2021 with a vision to increase transparency in the software supply chain through advanced program analysis, Binarly’s flagship platform has automated the discovery of hundreds of new vulnerabilities, preemptively addressing our customers' security risks before they could escalate. Binarly’s patented approach, powered by modern AI, has proactively ne
Making History: ASPIRE to Launch Inaugural ‘Abu Dhabi Autonomous Racing League’ Redefining Future of Extreme Sport on April 2723.4.2024 18:54:00 EEST | Press release
On Saturday, April 27th, Abu Dhabi will host a groundbreaking event, welcoming 10,000 spectators to witness the inaugural ASPIRE Abu Dhabi Autonomous Racing League (A2RL) at the iconic Yas Marina Circuit. This brand-new autonomous racing competition marks a significant milestone in motorsport history, billed as the largest league of its kind globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240423980323/en/ Making History: ASPIRE to Launch Inaugural ‘Abu Dhabi Autonomous Racing League’ Redefining Future of Extreme Sport on April 27 (Photo: AETOSWire) Eight teams will compete: Code19 Racing (one of the first independent autonomous racing entity from the USA), Constructor University (based in Germany and Switzerland), Fly Eagle (representing Beijing Institute of Technology from China and Khalifa University from the UAE), HUMDA Lab (a member of the Széchenyi István University Group from Hungary), KINETIZ (a collaboration
DataXstream Expands into Nordic Region with Successful Go Live for Martin & Servera23.4.2024 16:07:00 EEST | Press release
DataXstream LLC, an SAP solution provider focused on order management and point of sale for sales and distribution, today announced it is expanding into the Nordic region after a successful implementation of its OMS+ platform across two key business units for the Martin & Servera group, Sweden’s leading restaurant and catering distributor that specializes in the needs of the restaurant industry. Learn more about DataXstream OMS+ here. Martin & Servera is a group of companies based in Stockholm who was faced with the challenge of managing multiple ERP systems that were facing end of life, so they decided to consolidate onto a single instance of SAP S/4 HANA for all their business units. As part of this migration, Martin & Servera turned to DataXstream’s OMS+ cross-channel order management platform to help them enable faster order entry and streamline their sales and order processes between all companies within their organization. Working with DataXstream’s LATAM delivery team, Kötthalle
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom